Treatment of progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab-Reference-Cited by-同舟云学术

Treatment of progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab

Published:2015-03 Issue:3 Volume:22 Page:598-600
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Calic Z.,Cappelen-Smith C.,Hodgkinson S.J.,McDougall A.,Cuganesan R.,Brew B.J.

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference8 articles.

1. Progressive multifocal leukoencephalopathy and other forms of JC virus disease;Brew;Nat Rev Neurol,2010

2. Fingolimod after natalizumab and the risk of short-term relapse;Jokubaitis;Neurology,2014

3. Fingolimod recipient develops PML, likely linked to natalizumab. React Wkly 2012;1399:3.

4. Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice;Carruthers;Mult Scler Relat Disord,2014

5. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases;Clifford;Lancet Neurol,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fingolimod real life experience in non-naive multiple sclerosis patients;The European Research Journal;2024-09-04

2. Progressive multifocal leukoencephalopathy successfully treated with intravenous immunoglobulin;Neuroimmunology Reports;2024

3. A case of progressive multifocal leukoencephalopathy in a post-kidney transplant patient with improvement after discontinuation of immunosuppressive drugs and combination therapy with mefloquine and mirtazapine;Renal Replacement Therapy;2023-12-19

4. Therapeutic Experience of Progressive Multifocal Leukoencephalopathy Development during Ofatumumab Therapy for Chronic Lymphocytic Leukemia;Internal Medicine;2021-12-15

5. Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature;Journal of Neurology;2021-11-20